a pharmaceutical company with headquarters in india sells fluconazole, the generic version of pfizer's anti-fungal drug diflucan internationally for significantly less money than many u.s. generic drug manufacturers. the generic drugs industry in this country needs to rethink its strategy to stay competitive.
